Loading data
MSGENYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.06 bn USD | 942.73 m USD | 959.27 m USD | 779.82 m USD | 582.08 m USD |
| Selling, general and administrative expense | 253.11 m USD | 214.97 m USD | 206.96 m USD | 180.22 m USD | 167.13 m USD |
| Operating profit | 141.54 m USD | 122.09 m USD | 111.94 m USD | 105.01 m USD | -5.65 m USD |
| Interest expense | — | — | — | 51.87 m USD | 53.11 m USD |
| Profit before tax | 106.98 m USD | 65.56 m USD | 52.29 m USD | — | — |
| Income tax expense | 40.79 m USD | 28.13 m USD | -92.01 m USD | 1.73 m USD | -70 k USD |
| Net income (reported basis) | 66.19 m USD | 37.43 m USD | 144.3 m USD | 76.04 m USD | -133.34 m USD |
| Basic earnings per share | 1.39 USD/share | 0.78 USD/share | 2.99 USD/share | 1.48 USD/share | -2.58 USD/share |
| Diluted earnings per share | 1.38 USD/share | 0.77 USD/share | 2.97 USD/share | 1.47 USD/share | -2.58 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.